Product Details
Seretide 50 mcg/250 mcg Diskus Inhalation Powder
Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)250 mcg/Metered-Dose; 50 mcg/Metered-Dose
Inhalation powder
ROA
Inhalation, Oral
Applicant Name
GlaxoSmithKline Consumer Nigeria PLC (GSK)
NRN
04-3323
Status
Active
Composition
Each blister contains: Salmeterol as Salmeterol Xinafoate 50 mcg, Fluticasone Propionate 250 mcg
ATC Code/ATCvet Code
R03AK06
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 60's (in blister)
Product Description
Inhalation Powder
Manufacturer Name
GlaxoSmithKline LLC
Manufacturer Country
UNITED STATES OF AMERICA
Approval Date
2023-07-06
Expiry Date
2028-07-05